Retour
6
Également cotée sous
PIAHY
OTC
Fourchette du Jour
1,55 €
1,55 €
Fourchette 52 Semaines
0,78 €
2,45 €
Volume
100
Moyenne 50J / 200J
1,90 €
/
1,62 €
Clôture Précédente
1,76 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 41,0 | 0,4 |
| P/B | 0,9 | 2,9 |
| ROE % | 1,0 | 3,8 |
| Net Margin % | 1,7 | 3,9 |
| Rev Growth 5Y % | -8,5 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,29 €
0,26 € – 0,31 €
|
7,2 B | 1 |
| FY2026 |
0,17 €
0,16 € – 0,18 €
|
6,2 B | 1 |
Points Clés
Revenue declined -8,52% annually over 5 years
ROE of 0,97% is below average
Debt/Equity of 0,01 — conservative balance sheet
Generating 65,09M in free cash flow
P/E of 41,02 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11,40%
Croissance
Revenue Growth (5Y)
-8,52%
Revenue (1Y)2,88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
0,97%
ROIC-1,84%
Net Margin1,69%
Op. Margin-1,85%
Sécurité
Debt / Equity
0,01
Current Ratio1,02
Interest Coverage-26,20
Valorisation
P/E Ratio
41,02
P/B Ratio0,93
EV/EBITDAN/A
Dividend Yield1,54%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,88% | Revenue Growth (3Y) | -11,97% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8,52% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,81B | Net Income (TTM) | 81,43M |
| ROE | 0,97% | ROA | 0,49% |
| Gross Margin | 31,68% | Operating Margin | -1,85% |
| Net Margin | 1,69% | Free Cash Flow (TTM) | 65,09M |
| ROIC | -1,84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 1,02 |
| Interest Coverage | -26,20 | Dividend Yield | 1,54% |
| Valuation | |||
| P/E Ratio | 41,02 | P/B Ratio | 0,93 |
| P/S Ratio | 0,69 | PEG Ratio | -0,66 |
| EV/EBITDA | N/A | Dividend Yield | 1,54% |
| Market Cap | 3,34B | Enterprise Value | 1,34B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 4,81B | 4,67B | 6,21B | 7,33B | 6,87B |
| Net Income | 81,43M | -322,59M | -636,06M | -1,54B | -948,48M |
| EPS (Diluted) | 0,08 | -0,30 | -0,59 | -1,39 | -0,92 |
| Gross Profit | 1,52B | 1,51B | 1,67B | 1,71B | 1,86B |
| Operating Income | -89,06M | -575,26M | -726,34M | -1,64B | -919,14M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 16,78B | 16,52B | 17,14B | 17,88B | 18,56B |
| Total Liabilities | 13,20B | 3,25B | 3,68B | 3,79B | 2,71B |
| Shareholders' Equity | 3,59B | 13,28B | 13,46B | 14,08B | 15,83B |
| Total Debt | 45,00M | 93,61M | 176,49M | 201,30M | 113,97M |
| Cash & Equivalents | 2,04B | 1,87B | 3,70B | 3,06B | 7,92B |
| Current Assets | 13,40B | 13,33B | 12,46B | 12,76B | 15,26B |
| Current Liabilities | 13,08B | 3,10B | 3,45B | 3,67B | 2,67B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#805 of 820
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026